Stephen S. Opat

246 Clayton Road
Clayton, VIC 3168, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 142 publications

Significant variations in first-line mantle cell lymphoma care-an Australasian Lymphoma and Related Diseases Registry study.

Significant variations in first-line mantle cell lymphoma care-an Australasian Lymphoma and Related Diseases Registry study.

Journal: Leukemia & lymphoma
Published: May 26, 2026

Prognostic survival models for diffuse large B-cell lymphoma using statistical and machine learning approaches.

Prognostic survival models for diffuse large B-cell lymphoma using statistical and machine learning approaches.

Journal: NPJ precision oncology
Published: March 02, 2026

Coronavirus disease 2019 (COVID-19) risk and evolving treatment patterns in follicular lymphoma during the pandemic: Insights from the PETReA trial.

Coronavirus disease 2019 (COVID-19) risk and evolving treatment patterns in follicular lymphoma during the pandemic: Insights from the PETReA trial.

Journal: British journal of haematology
Published: February 18, 2026

Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.

Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.

Journal: Blood advances
Published: February 05, 2026

Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Journal: Blood advances
Published: February 05, 2026

Australasian chronic lymphocytic leukaemia consensus statement: 2026 update.

Australasian chronic lymphocytic leukaemia consensus statement: 2026 update.

Journal: Internal medicine journal
Published: January 06, 2026

End-of-treatment positron emission tomography/computed tomography complete remission is highly prognostic in nodal peripheral T-cell lymphoma: An Australasian-Canadian collaborative study.

End-of-treatment positron emission tomography/computed tomography complete remission is highly prognostic in nodal peripheral T-cell lymphoma: An Australasian-Canadian collaborative study.

Journal: British journal of haematology
Published: December 29, 2025

Development and Validation of Prognostic Models for Treatment Response of Patients with B-Cell Lymphoma: Standard Statistical and Machine-Learning Approaches.

Development and Validation of Prognostic Models for Treatment Response of Patients with B-Cell Lymphoma: Standard Statistical and Machine-Learning Approaches.

Journal: Journal of clinical medicine
Published: September 18, 2025

Phase 3 PERSPECTIVE study: Ibrutinib with rituximab for initial treatment of patients with follicular lymphoma.

Phase 3 PERSPECTIVE study: Ibrutinib with rituximab for initial treatment of patients with follicular lymphoma.

Journal: HemaSphere
Published: September 17, 2025

Zanubrutinib in the treatment of Waldenström Macroglobulinemia.

Zanubrutinib in the treatment of Waldenström Macroglobulinemia.

Journal: Future oncology (London, England)
Published: September 11, 2025

Too soon to reject immunoglobulin replacement in CLL.

Too soon to reject immunoglobulin replacement in CLL.

Journal: Blood advances
Published: August 08, 2025

Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trial.

Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trial.

Journal: Blood
Published: July 25, 2025
Showing 1-12 of 142

Last Updated: 09/26/2026